immuneCODE launch Learn more about the data Read the press release ImmuneCODE™ Launched De-identified COVID-19 immune response data available to help accelerate solutions to the pandemic 1,591,818,320 TCRs Sequenced 6,350 Samples clonoseq Learn more Read our press release clonoSEQ® is now FDA-cleared
for MRD assessment in patients with Chronic Lymphocytic Leukemia (CLL).
clonoSEQ® is available as a FDA-cleared in vitro diagnostic (IVD) test service provided by Adaptive Biotechnologies to detect minimal residual disease (MRD) in bone marrow samples from patients with multiple myeloma or B-cell acute lymphoblastic leukemia (B-ALL) , and blood or bone marrow from patients with chronic lymphocytic leukemia (CLL). clonoSEQ is also available for use in other lymphoid cancers as a CLIA-regulated laboratory developed test (LDT) service. For important information about the FDA-cleared uses of clonoSEQ including test limitations, please visit clonoSEQ.com/technical-summary.
TMAP COVID Learn more Read the press release Now providing you the powerful tools you need to fully understand the T-cell response in COVID-19 NOW AVAILABLE For Research Use Only. Not for use in diagnostic procedures.
Learn more
Developing Therapeutic Antibodies Against COVID-19
Every immune system has a story to tell. The key is knowing how to listen. At Adaptive, we’re writing the next chapter of precision health — powered by immune-driven medicine.
OUR STORY

Pioneers in immune-driven medicine

Our goal is to meaningfully improve people’s lives by learning from the wisdom of their adaptive immune systems. It’s a bold objective that we’re uniquely built to achieve.

OUR PROPRIETARY PLATFORM

The evolution of our immune-driven medicine platform

The adaptive immune system is nature’s most finely tuned diagnostic and therapeutic. Our platform reveals its enormous diversity and scale.

A WORLD-CLASS TEAM

Become an Adapter

We’re looking for curious, passionate people to help us write the future of immune-driven medicine.

Convergent Team

Juxtaposing disciplines leads to discoveries in our field.

Innovative Thinkers

Open minds explore the unimaginable.

Adventure

Pioneering spirit makes us first to break new ground.

 Keep up to date with Adaptive. Join our newsletter.

back_to_top